Cargando…

Induction of allergen-specific blocking IgG using patch delivered recombinant Bet v 1 in guinea pigs

Detalles Bibliográficos
Autores principales:	Cabauatan, Clarissa, Campana, Raffaela, Niespodziana, Katarzyna, Reinisch, Christoph, Lundberg, Urban, Meinke, Andreas, Henning, Rainer, Neubauer, Angela, Valenta, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072013/ http://dx.doi.org/10.1186/2045-7022-4-S2-O18

Ejemplares similares

Heat‐labile Escherichia coli toxin enhances the induction of allergen‐specific IgG antibodies in epicutaneous patch vaccination
por: Cabauatan, C. R., et al.
Publicado: (2016)

Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments
por: Campana, Raffaela, et al.
Publicado: (2015)

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
por: Valenta, Rudolf, et al.
Publicado: (2016)

Recombinant allergy vaccines based on allergen-derived B cell epitopes
por: Valenta, Rudolf, et al.
Publicado: (2017)

Novel vaccines for allergen-specific immunotherapy
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies
por: Niespodziana, Katarzyna, et al.
Publicado: (2022)

Determination of IgE and IgG reactivity to more than 170 allergen molecules in paper-dried blood spots
por: Garib, Victoria, et al.
Publicado: (2018)

Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients
por: Campana, Raffaela, et al.
Publicado: (2017)

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines
por: Weber, Milena, et al.
Publicado: (2017)

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
por: Campana, Raffaela, et al.
Publicado: (2018)

Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
por: Curin, Mirela, et al.
Publicado: (2018)

Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms
por: Niespodziana, Katarzyna, et al.
Publicado: (2014)

Trimolecular complex between major birch pollen allergen, Bet v 1, monoclonal allergen-specific human IgE and recombinant CD23
por: Selb, Regina, et al.
Publicado: (2014)

Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy
por: Flicker, Sabine, et al.
Publicado: (2013)

Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma
por: Naumova, Veronika, et al.
Publicado: (2022)

Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response
por: Borochova, Kristina, et al.
Publicado: (2021)

Betamethasone prevents human rhinovirus- and cigarette smoke- induced loss of respiratory epithelial barrier function
por: Waltl, Eva E., et al.
Publicado: (2018)

Antibody Conjugates Bispecific for Pollen Allergens and ICAM-1 with Potential to Prevent Epithelial Allergen Transmigration and Rhinovirus Infection
por: Weichwald, Christina, et al.
Publicado: (2023)

Microarrayed dog, cat, and horse allergens show weak correlation between allergen-specific IgE and IgG responses(⋆)()
por: Curin, Mirela, et al.
Publicado: (2014)

Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
por: Tulaeva, Inna, et al.
Publicado: (2020)

Maternal allergen-specific IgG might protect the child against allergic sensitization
por: Lupinek, Christian, et al.
Publicado: (2019)

Isolation of a high‐affinity Bet v 1‐specific IgG‐derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments
por: Gadermaier, E., et al.
Publicado: (2018)

Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?
por: Valenta, Rudolf, et al.
Publicado: (2018)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

The role of allergen‐specific IgE, IgG and IgA in allergic disease
por: Shamji, Mohamed H., et al.
Publicado: (2021)

Transmission of allergen-specific IgG and IgE from maternal blood into breast milk visualized with microarray technology
por: Hochwallner, Heidrun, et al.
Publicado: (2014)

Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG(1) and IgG(4) against the Major Birch Pollen Allergen Bet v 1
por: Köhler, Verena K., et al.
Publicado: (2020)

Microarray Technology May Reveal the Contribution of Allergen Exposure and Rhinovirus Infections as Possible Triggers for Acute Wheezing Attacks in Preschool Children
por: Niespodziana, Katarzyna, et al.
Publicado: (2021)

Monitoring Allergen Immunotherapy Effects by Microarray
por: Lupinek, Christian, et al.
Publicado: (2016)

Genetic Variants in CHIA and CHI3L1 Are Associated with the IgE Response to the Ascaris Resistance Marker ABA-1 and the Birch Pollen Allergen Bet v 1
por: Acevedo, Nathalie, et al.
Publicado: (2016)

In-print of the environment on the molecular sensitisation profile towards pollen allergens revealed by allergen micro-array
por: Garib, Viktoriya, et al.
Publicado: (2014)

Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations
por: Husslik, Felix, et al.
Publicado: (2015)

The History and Science of the Major Birch Pollen Allergen Bet v 1
por: Breiteneder, Heimo, et al.
Publicado: (2023)

Profound differences in IgE and IgG recognition of micro‐arrayed allergens in hyper‐IgE syndromes
por: Garib, Victoria, et al.
Publicado: (2021)

Anaphylaxis induced by inhaling guinea pig allergen
por: Tang, Rui, et al.
Publicado: (2021)

PreDicta chip-based high resolution diagnosis of rhinovirus-induced wheeze
por: Niespodziana, Katarzyna, et al.
Publicado: (2018)

IgE, IgG4 and IgA specific to Bet v 1-related food allergens do not predict oral allergy syndrome
por: Guhsl, E E, et al.
Publicado: (2015)

Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
por: Linhart, B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5uusfsmfhv2l983boufa2hf51r